Titterton Lewis H jr purchased $7K of ANIX
Titterton Lewis H jr purchased 2,836 shares of Anixa Biosciences Inc (ANIX) at $2.64 on 2026-06-16.
How this was made
The 30-second read
Why it matters
The newest fact is the director’s open-market purchase details (shares, price, total value) disclosed on 2026-06-17 for a trade dated 2026-06-16.
Market read
Traders may treat the filing as a small sentiment input, but it does not provide new fundamentals or guidance.
What to watch
Check whether the director has a history of buys/sells and whether there are concurrent corporate events (financing, trial updates) not mentioned here.
Background
The article is an SEC Form 4 insider transaction disclosure for Anixa Biosciences (ANIX).
Ticker impact
Anixa Biosciences director Titterton Lewis H jr filed a Form 4 open-market purchase of 2,836 shares at $2.6400 on 2026-06-16.
Near-term impact likely limited; any reaction would be sentiment-driven rather than fundamental.
The disclosure is a routine Form 4 insider purchase with no new operational/financial catalyst, and the transaction size is small relative to typical market-moving thresholds.
Market effects
Minimal; single-company insider transaction without sector-wide signal.
None indicated.
None indicated.
Counterpoint
Insider buys can be discretionary and may not reflect a durable thesis; without a 10b5-1 plan, timing could be opportunistic rather than informational.
Key entities
- issuerAnixa Biosciences Inc
Subject of the Form 4 insider transaction disclosure.
- insiderTitterton Lewis H jr
Director who reported an open-market purchase of ANIX shares.